Revolution Medicines, Inc. (RVMD) has 98 open-market insider trades by 18 insiders since 2020. Over the last six months insiders net sold $720K. The most active filer is Mark A. Goldsmith.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Peter Svennilson | Dir | — | 4 | $158.0M | 2021-04-28 |
| Thilo Schroeder | Dir | — | 9 | $142.2M | 2024-12-05 |
| TRV GP Ii, LLC | 10% Owner | — | 1 | $79.4M | 2021-05-26 |
| Column GROUP Iii-a, L.P. | 10% Owner | — | 1 | $73.8M | 2020-11-16 |
| Robert I. Tepper | 10% Owner | — | 2 | $49.8M | 2022-06-08 |
| Mark A. Goldsmith | — | — | 15 | $15.2M | 2026-09-16 |
| Margaret A. Horn | COO | — | 15 | $13.3M | 2026-09-16 |
| Deerfield Management Company, L.P. (series C) via Keith Crandell | 10% Owner | — | 1 | $5.1M | 2020-02-18 |
| Stephen Michael Kelsey | — | — | 15 | $3.2M | 2026-09-16 |
| Barbara Weber | Dir | — | 5 | $1.5M | 2024-10-08 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Alan B. Sandler | — | Sell | $1.3M | 2026-09-29 |
| Jeff Cislini | CLO & VP | Sell | $159K | 2026-09-25 |
| Anthony Mancini | — | Sell | $743K | 2026-09-24 |
| Elizabeth M. Anderson | Director | Sell | $2.0M | 2026-09-22 |
| Anthony Mancini | — | Sell | $347K | 2026-09-18 |
| Alan B. Sandler | — | Sell | $68K | 2026-09-16 |
Companies that share insiders with RVMD, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Margaret A. Horn | COO | Sell | $990K | 2026-09-16 |
| Jeff Cislini | CLO & VP | Sell | $671K | 2026-09-16 |
| Anthony Mancini | — | Sell | $353K | 2026-09-16 |
| Stephen Michael Kelsey | — | Sell | $1.1M | 2026-09-16 |
| Mark A. Goldsmith | — | Sell | $2.8M | 2026-09-16 |
| Jack Anders | CFO | Sell | $808K | 2026-09-16 |
| Stephen Michael Kelsey | — | Sell | $18.7M | 2026-09-11 |
| Anthony Mancini | — | Sell | $3.2M | 2026-09-10 |
| Lorence H. Kim | Director | Sell | $3.6M | 2026-09-08 |